Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $6.9 million.

  • Xtant Medical Holdings' Accounts Payables fell 1737.77% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year decrease of 1737.77%. This contributed to the annual value of $7.9 million for FY2024, which is 1224.84% up from last year.
  • Per Xtant Medical Holdings' latest filing, its Accounts Payables stood at $6.9 million for Q3 2025, which was down 1737.77% from $7.2 million recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' Accounts Payables ranged from a high of $8.3 million in Q3 2024 and a low of $2.4 million during Q3 2021
  • Moreover, its 5-year median value for Accounts Payables was $4.4 million (2023), whereas its average is $5.0 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first tumbled by 3100.58% in 2021, then surged by 11566.79% in 2024.
  • Xtant Medical Holdings' Accounts Payables (Quarter) stood at $2.6 million in 2021, then surged by 33.46% to $3.5 million in 2022, then skyrocketed by 102.12% to $7.1 million in 2023, then increased by 12.25% to $7.9 million in 2024, then fell by 13.41% to $6.9 million in 2025.
  • Its last three reported values are $6.9 million in Q3 2025, $7.2 million for Q2 2025, and $7.1 million during Q1 2025.